申请人:Bristol-Myers Squibb Company
公开号:US05162524A1
公开(公告)日:1992-11-10
This invention relates to a novel process for making a cephem of formula II from a 2-(3-amino-2-oxo-azetidin-1-yl)-2,3-butadienoate intermediate of formula I using an organo-copper reagent. In another aspect, this invention is concerned with said intermediate. ##STR1## In the compounds of Scheme (A), R.sup.1 is a conventional amino protecting group or an acyl group; R.sup.2 is an aromatic heterocyclic or aryl group; R.sup.3 is a conventional carboxy protecting group or --CO.sub.2 R.sup.3 taken together forms a physiologically hydrolyzable ester; and R.sup.4 is a group selected from the group consisting of C.sub.1-6 alkyl, C.sub.2-6 alkenyl, C.sub.2-6 alkynyl, cyclic C.sub.3-6 alkyl, and aryl; and n is 0 or 2. This invention also relates to an intermediate represented by formula ##STR2## in which R.sup.1, R.sup.2, R.sup.3 and n are as defined above.
这项发明涉及一种从式I的2-(3-氨基-2-氧代氮杂环丙氧基)-2,3-丁二烯酸酯中使用有机铜试剂制备式II头孢菌素的新工艺。在另一个方面,这项发明涉及所述的中间体。在方案(A)的化合物中,R^1是传统的氨基保护基或酰基;R^2是芳香杂环或芳基;R^3是传统的羧基保护基或--CO_2R^3,两者结合形成生理可水解的酯;R^4是选自C_1-6烷基、C_2-6烯基、C_2-6炔基、环状C_3-6烷基和芳基的基团;n为0或2。这项发明还涉及一种由式所表示的中间体
R^1、R^2、R^3和n如上定义。